文献速递分子诊断临床免疫

Kallmann综合征:诊断与管理

Kallmann syndrome: Diagnostics and management.
PubMed 文献 · Clin Chim Acta · 2024-10-09

本文综述Kallmann综合征的遗传诊断与管理策略,重点聚焦KAL1基因突变。Kallmann综合征是遗传异质性疾病,以低促性腺激素性性腺功能减退和嗅觉缺失为特征。KAL1基因胚系突变在8%的患者中被发现,产前诊断和胚胎植入前遗传学检测是降低下一代风险的最重要方法。

要点

  • Kallmann综合征由低促性腺激素性性腺功能减退和嗅觉缺失组成。
  • KAL1基因胚系突变见于8%的Kallmann综合征患者。
  • 产前诊断和胚胎植入前遗传学检测可降低下一代患病风险。

核心结论

  • Kallmann综合征是遗传异质性疾病,KAL1基因突变是已知病因之一,早期诊断和遗传检测有助于预防并发症和降低后代风险。

研究设计与样本

  • 本文为综述,检索近期文献,总结Kallmann综合征的遗传诊断与管理策略,重点关注KAL1基因突变。

主要发现

  • KAL1基因胚系突变在8%的Kallmann综合征患者中被识别。
  • KAL1突变患者可见小生殖器、阳痿、性欲减退、不育、单侧肾缺如和联带运动等临床表现。
  • Kallmann综合征可呈X连锁隐性(如KAL1突变)、常染色体显性和隐性遗传。

关键数值与推荐

  • KAL1基因胚系突变见于8%的Kallmann综合征患者。

临床怎么用

  • 通过产前诊断和胚胎植入前遗传学检测降低下一代Kallmann综合征风险。
  • 早期诊断、饮食补充和药物治疗可预防Kallmann综合征相关并发症。
  • 治疗目标包括促进第二性征发育、维持骨密度和肌肉量以及恢复生育能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Kallmann syndrome is a genetic disorder characterized by delayed or absence of puberty and a reduced or absent sense of smell (anosmia). Kallmann syndrome is a form of hypogonadotropic hypogonadism due to lack of the production of sex hormones which is associated with development of secondary sexual characteristics. Kallmann Syndrome is a genetically heterogeneous disorder, characterized by the combination of hypogonadotropic hypogonadism (a deficiency in sex hormone production) and anosmia. Germline mutations in KAL1 gene causes deficiency in GnRH hormone followed by low level of circulating gonadotropin and testosterone which finally leads to the failure of puberty (development of secondary sexual characters). Kallmann Syndrome can be inherited in several manners including X-linked recessive (e.g., mutations within KAL1) and autosomal dominant and recessive forms. Germline mutation in KAL1 gene was identified among 8% of patients with Kallmann Syndrome. A review of the recent literature done reveals numerous clinical manifestations in Kallmann Syndrome patients with the KAL1 mutation, including microgenitalia, impotence, reduced libido, infertility, unilateral renal agenesis, and synkinesia. Genetic molecular diagnostics through prenatal diagnosis and preimplantation genetic testing are most significant way to reduce the risk of Kallmann syndrome in next generation. Complication associated with Kallmann syndrome can be prevented by early diagnosis, diet supplementation and medical therapy. Goal of therapeutic intervention is to the development of secondary sexual characteristics, build and sustain bone density as well as muscle mass and restore fertility. This review aims to explore the genetic diagnosis and management strategies for Kallmann Syndrome, particularly focusing on KAL1 gene mutations.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Kumar Yadav R, Qi B, Wen J, et al. Kallmann syndrome: Diagnostics and management. Clin Chim Acta. 2024. PMID: 39384129. doi:10.1016/j.cca.2024.119994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。